SS
NAGE

SBI Securities’s Niagen Bioscience NAGE Stock Holding History

SBI Securities’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$890 Sell
279
-8
-3% -$32 ﹤0.01% 2843
2026
Q1 		$1.27K Buy
287
+116
+68% +$626 ﹤0.01% 2565
2025
Q4 		$1.09K Sell
171
-121
-41% -$842 ﹤0.01% 2612
2025
Q3 		$2.72K Sell
292
-99
-25% -$1K ﹤0.01% 2306
2025
Q2 		$5.63K Buy
391
+70
+22% +$691 ﹤0.01% 1932
2025
Q1 		$2.21K Buy
321
+19
+6% +$119 ﹤0.01% 2241
2024
Q4 		$1.6K Buy
+302
New +$1.65K ﹤0.01% 2386

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SBI Securities's NAGE Position: Q2 2026 in Review

SBI Securities reduced its Niagen Bioscience (NAGE) stake by 2.8% in Q2 2026, selling an estimated $32 and leaving 279 shares worth $890. The position accounts for ﹤0.01% of the portfolio, ranked #2843.

SBI Securities first reported a position in NAGE in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.63K in Q2 2025. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • SBI Securities held 279 shares of Niagen Bioscience worth $890 as of Q2 2026.
  • SBI Securities sold 8 Niagen Bioscience shares in Q2 2026, an estimated $32.
  • Niagen Bioscience made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2843 holding.
  • SBI Securities first reported a position in Niagen Bioscience in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Niagen Bioscience position peaked at $5.63K in Q2 2025.
  • 140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.